Overview

Study to Investigate Effects of Repeated Administration of Itraconazole on Pharmacokinetics of JNJ-42847922 in Healthy Male Participants

Status:
Completed

Trial end date:
2015-06-19

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the effects of repeated once daily administration of 200 milligram (mg) of itraconazole (steady state) on the single-dose pharmacokinetics of JNJ 42847922 in healthy, male participants.

Phase:

Phase 1

Details

Lead Sponsor:

Janssen Cilag N.V./S.A.

Treatments:

Hydroxyitraconazole
Itraconazole